HHS Inspector General Postpones Study Of FDA Conflict-Of-Interest Oversight
This article was originally published in The Gray Sheet
Executive Summary
The HHS Office of Inspector General announced it will postpone a study of FDA and instead focus its conflict-of-interest enforcement efforts on the National Institutes of Health this year